Abstract
Neurodegenerative processes associated with Alzheimer’s disease (AD) are accompanied by reactive astrogliosis and microglia activation and a role for chronic inflammation in the brain degeneration of these patients has been suggested. Moreover impaired immune functions in AD brains might also influence the disease’s progression. Therefore, it is of interest to further characterized inflammatory molecules in the peripheral blood of patients with AD and its relationship with cognitive decline. A complex picture emerged in this pilot study and IL-8, IFN-gamma, MCP-1 and VEGF levels were increased in AD. Levels of P-selectin and L-selectin were decreased in AD and lowest in AD patients with highest cognitive decline. Our findings suggest that these molecules may induce alterations of endothelial regulation and influence neurodegenerative processes of AD.
Similar content being viewed by others
References
Alegret M, Vinyes-Junqué G, Boada M, Martínez-Lage P, Cuberas G, Espinosa A, Roca I, Hernández I, Valero S, Rosende-Roca M, Mauleón A, Becker JT, Tárraga L (2010) Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer’s disease. J Alzheimers Dis 21(2):557–567
American Psychiatric Association (1997) Diagnostic and statistical manual of mental disorders: DSM-III-R, vol 58, 3rd edn. American Psychiatric Association, Washington
Borroni B, Akkawi N, Martini G, Colciaghi F, Prometti P, Rozzini L, Di Luca M, Lenzi GL, Romanelli G, Caimi L, Padovani A (2002) Microvascular damage and platelet abnormalities in early Alzheimer’s disease. J Neurol Sci 203–204:189–193
Chiappelli M, Borroni B, Archetti S, Calabrese E, Corsi MM, Franceschi M, Padovani A, Licastro F (2006a) VEGF gene and phenotype relation with Alzheimer’s disease and mild cognitive impairment. Rejuvenation Res 9:485–493
Chiappelli M, Tumini E, Porcellini E, Licastro F (2006b) Impaired regulation of immune response in cognitive decline and Alzheimer’s disease: lessons from genetic association studies. Expert Rev Neurother 6:1327–1336
Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56:321–339
Doody RS, Massman P, Dunn JK (2001) A method for estimating progression rates in Alzheimer disease. Arch Neurol 58(3):449–454
Eikelenboom P, Zhan SS, Kamphorst W, van der Valk P, Rozemuller JM (1994) Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer’s disease. Virchows Arch 424(4):421–427
Engelhardt B, Ransohoff RM (2005) The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 26:485–495
Ewers M, Mielke MM, Hampel H (2010) Blood-based biomarkers of microvascular pathology in Alzheimer’s disease. Exp Gerontol 45(1):75–79
Gamble JR, Skinner MP, Berndt MC, Vadas MA (1990) Prevention of activated neutrophil adhesion endothelium by soluble adhesion protein GMP140. Science 249:414–417
Hochstrasser T, Weiss E, Marksteiner J, Humpel C (2010) Soluble cell adhesion molecules in monocytes of Alzheimer’s disease and mild cognitive impairment. Exp Gerontol 45(1):70–74
Khalil Z, LoGiudice D, Khodr B, Maruff P, Masters C (2007) Impaired peripheral endothelial microvascular responsiveness in Alzheimer’s disease. J Alzheimers Dis 11(1):25–32
Licastro F, Chiappelli M, Ruscica M, Carnelli V, Corsi MM (2005) Altered cytokine and acute phase response protein levels in the blood of children with Downs syndrome: relationship with dementia of Alzheimer’s type. Int J Immunopathol Pharmacol 18:165–172
Licastro F, Chiappelli M, Caldarera CM, Porcellini E, Carbone I, Caruso C, Lio D, Corder EH (2011) Sharing pathogenetic mechanisms between acute myocardial infarction and Alzheimer’s disease as shown by partially overlapping of gene variant profiles. J Alzheimer Dis 23:421–431
Luckhaus C, Cohnen M, Flüss MO, Jänner M, Grass-Kapanke B, Teipel SJ, Grothe M, Hampel H, Peters O, Kornhuber J, Maier W, Supprian T, Gaebel W, Mödder U, Wittsack HJ (2010) The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer’s dementia. Psychiatry Res 183(1):44–51
Nielsen HM, Londos E, Minthon L, Janciauskiene SM (2007) Soluble adhesion molecules and angiotensin-converting enzyme in dementia. Neurobiol Dis 26(1):27–35
Rentzos M, Michalopoulou M, Nikolaou C, Cambouri C, Rombos A, Dimitrakopoulos A, Vassilopoulos D (2005) The role of soluble intercellular adhesion molecules in neurodegenerative disorders. J Neurol Sci 228(2):129–135
Rosendorff C, Beeri MS, Silverman JM (2007) Cardiovascular risk factors for Alzheimer’s disease. Am J Geriatr Cardiol 16(3):143–149
Stefani A, Sancesario G, Pierantozzi M, Leone G, Galati S, Hainsworth AH, Diomedi M (2009) CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer’s and mixed dementia. J Neurol Sci 283(1–2):109–115
Conflict of interest
None to be declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Corsi, M.M., Licastro, F., Porcellini, E. et al. Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration. Biogerontology 12, 451–454 (2011). https://doi.org/10.1007/s10522-011-9335-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10522-011-9335-6